SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects

<p>Abstract</p> <p>Background</p> <p>The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rat...

Full description

Bibliographic Details
Main Authors: Qiu Ruofeng, Cai Anping, Dong Yugang, Zhou Yingling, Yu Danqing, Huang Yuli, Zheng Dongdan, Rao Shaoqi, Feng Yingqing, Mai Weiyi
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Journal of Biomedical Science
Subjects:
Online Access:http://www.jbiomedsci.com/content/19/1/99
_version_ 1818235247088631808
author Qiu Ruofeng
Cai Anping
Dong Yugang
Zhou Yingling
Yu Danqing
Huang Yuli
Zheng Dongdan
Rao Shaoqi
Feng Yingqing
Mai Weiyi
author_facet Qiu Ruofeng
Cai Anping
Dong Yugang
Zhou Yingling
Yu Danqing
Huang Yuli
Zheng Dongdan
Rao Shaoqi
Feng Yingqing
Mai Weiyi
author_sort Qiu Ruofeng
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI.</p> <p>Methods</p> <p>Male Sprague–Dawley rats were underwent permanent coronary artery ligation and randomly assigned into four groups as follow: blank control (B), atorvastatin (A), atorvastatin plus L-NAME (A+L-NAME), and atorvastatin plus AMD3100 (A+AMD3100). Rats underwent similar procedure but without ligation were used as group sham operated (S). Atorvastatin (10mg/Kg/d body weight) was administrated by gavage to rats in three atorvastatin treated groups, and L-NAME (40mg/Kg/d body weight) or AMD3100 (5mg/Kg/d body weight) was given to group A+L-NAME or A+AMD3100, respectively.</p> <p>Results</p> <p>Comparing with group B, NO production, SDF-1α and CXCR4 expression were significantly up-regulated in three atorvastatin treated groups at the seventh day. However, the increments of SDF-1α and CXCR4 expression in group A+L-NAME were reduced when NO production was inhibited by L-NAME. Anti-inflammatory and anti-apoptotic effects of atorvastatin were offset either by decrease of SDF-1α and CXCR4 expression (by L-NAME) or blockage of SDF-1α coupling with CXCR4 (by AMD3100). Expression of STAT3, a cardioprotective factor mediating SDF-1α/CXCR4 axis induced cardiac protection, was up-regulated most significantly in group A. The effects of atorvastatin therapy on cardiac function were also abrogated either when SDF-1α and CXCR4 expression was diminished or the coupling of SDF-1α with CXCR4 was blocked.</p> <p>Conclusion</p> <p>SDF-1α upregulation by atorvastatin in rats with AMI was, at least partially, via the eNOS/NO dependent pathway, and SDF-1α upregulation and SDF-1α coupling with CXCR4 conferred anti-inflammatory and anti-apoptotic effects under AMI setting which we speculated that ultimately contributed to cardiac function improvement.</p>
first_indexed 2024-12-12T11:50:56Z
format Article
id doaj.art-4ccbc5fdc90245c1a4441460f86348d9
institution Directory Open Access Journal
issn 1021-7770
1423-0127
language English
last_indexed 2024-12-12T11:50:56Z
publishDate 2012-11-01
publisher BMC
record_format Article
series Journal of Biomedical Science
spelling doaj.art-4ccbc5fdc90245c1a4441460f86348d92022-12-22T00:25:19ZengBMCJournal of Biomedical Science1021-77701423-01272012-11-011919910.1186/1423-0127-19-99SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effectsQiu RuofengCai AnpingDong YugangZhou YinglingYu DanqingHuang YuliZheng DongdanRao ShaoqiFeng YingqingMai Weiyi<p>Abstract</p> <p>Background</p> <p>The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI.</p> <p>Methods</p> <p>Male Sprague–Dawley rats were underwent permanent coronary artery ligation and randomly assigned into four groups as follow: blank control (B), atorvastatin (A), atorvastatin plus L-NAME (A+L-NAME), and atorvastatin plus AMD3100 (A+AMD3100). Rats underwent similar procedure but without ligation were used as group sham operated (S). Atorvastatin (10mg/Kg/d body weight) was administrated by gavage to rats in three atorvastatin treated groups, and L-NAME (40mg/Kg/d body weight) or AMD3100 (5mg/Kg/d body weight) was given to group A+L-NAME or A+AMD3100, respectively.</p> <p>Results</p> <p>Comparing with group B, NO production, SDF-1α and CXCR4 expression were significantly up-regulated in three atorvastatin treated groups at the seventh day. However, the increments of SDF-1α and CXCR4 expression in group A+L-NAME were reduced when NO production was inhibited by L-NAME. Anti-inflammatory and anti-apoptotic effects of atorvastatin were offset either by decrease of SDF-1α and CXCR4 expression (by L-NAME) or blockage of SDF-1α coupling with CXCR4 (by AMD3100). Expression of STAT3, a cardioprotective factor mediating SDF-1α/CXCR4 axis induced cardiac protection, was up-regulated most significantly in group A. The effects of atorvastatin therapy on cardiac function were also abrogated either when SDF-1α and CXCR4 expression was diminished or the coupling of SDF-1α with CXCR4 was blocked.</p> <p>Conclusion</p> <p>SDF-1α upregulation by atorvastatin in rats with AMI was, at least partially, via the eNOS/NO dependent pathway, and SDF-1α upregulation and SDF-1α coupling with CXCR4 conferred anti-inflammatory and anti-apoptotic effects under AMI setting which we speculated that ultimately contributed to cardiac function improvement.</p>http://www.jbiomedsci.com/content/19/1/99Acute myocardial infarctionAtorvastatinStromal cell derived factor-1alpha
spellingShingle Qiu Ruofeng
Cai Anping
Dong Yugang
Zhou Yingling
Yu Danqing
Huang Yuli
Zheng Dongdan
Rao Shaoqi
Feng Yingqing
Mai Weiyi
SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
Journal of Biomedical Science
Acute myocardial infarction
Atorvastatin
Stromal cell derived factor-1alpha
title SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_full SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_fullStr SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_full_unstemmed SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_short SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_sort sdf 1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti inflammatory and anti apoptotic effects
topic Acute myocardial infarction
Atorvastatin
Stromal cell derived factor-1alpha
url http://www.jbiomedsci.com/content/19/1/99
work_keys_str_mv AT qiuruofeng sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT caianping sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT dongyugang sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT zhouyingling sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT yudanqing sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT huangyuli sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT zhengdongdan sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT raoshaoqi sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT fengyingqing sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT maiweiyi sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects